Cuu Long Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
Cuu Long Pharmaceutical has a total shareholder equity of ₫1,480.3B and total debt of ₫708.4B, which brings its debt-to-equity ratio to 47.9%. Its total assets and total liabilities are ₫2,414.0B and ₫933.7B respectively. Cuu Long Pharmaceutical's EBIT is ₫88.2B making its interest coverage ratio -9.7. It has cash and short-term investments of ₫221.9B.
Key information
47.9%
Debt to equity ratio
₫708.42b
Debt
Interest coverage ratio | -9.7x |
Cash | ₫221.90b |
Equity | ₫1.48t |
Total liabilities | ₫933.70b |
Total assets | ₫2.41t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DCL's short term assets (₫1,513.8B) exceed its short term liabilities (₫679.2B).
Long Term Liabilities: DCL's short term assets (₫1,513.8B) exceed its long term liabilities (₫254.5B).
Debt to Equity History and Analysis
Debt Level: DCL's net debt to equity ratio (32.9%) is considered satisfactory.
Reducing Debt: DCL's debt to equity ratio has reduced from 97% to 47.9% over the past 5 years.
Debt Coverage: DCL's debt is not well covered by operating cash flow (0.5%).
Interest Coverage: DCL earns more interest than it pays, so coverage of interest payments is not a concern.